Back
CytomX Therapeutics, Inc. Stock Predictions
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
CTMX
CytomX Therapeutics, Inc.
Last Price:
$5.64
Seasonality Move:
-6.55%
7 Day Trial
ALL ACCESS PASS
$
7
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atCytomX Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, CytomX Therapeutics, Inc. has on average historically risen by 43.7% based on the past 10 years of stock performance.
-
CytomX Therapeutics, Inc. has risen higher in 2 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
-
Is CytomX Therapeutics, Inc. Stock Undervalued?The current CytomX Therapeutics, Inc. [CTMX] share price is $5.67. The Score for CTMX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CTMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CytomX Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, CytomX Therapeutics, Inc. has on average historically risen by 43.7% based on the past 10 years of stock performance.
CytomX Therapeutics, Inc. Stock Rating
Sell
50
CytomX Therapeutics, Inc. (CTMX)
is a Sell
Is CytomX Therapeutics, Inc. overpriced?
-
CytomX Therapeutics, Inc. has risen higher in 2 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
CytomX Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com
52-Week Data
52-Week High:
6.35
52-Week Low:
0.40
Prediction Charts
Market Cap:
960.7M
Price in USD:
5.67
Volume:
3.6M
Beta:
1.50
Technical Analysis
SMA50:
4.58
SMA100:
3.92
SMA200:
2.99
52-Wk Change:
551.72%
Stock Predictions
-
Is CytomX Therapeutics, Inc. stock public?Yes, CytomX Therapeutics, Inc. is a publicly traded company.
-
What is the CytomX Therapeutics, Inc. stock quote today?The CytomX Therapeutics, Inc. stock price is 5.67 USD today.
-
How to buy CytomX Therapeutics, Inc. stock online?You can buy CytomX Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 5.46 | 5.37 | 5.61 | 5.10 |
| Jan-21 | 5.28 | 5.29 | 5.42 | 5.04 |
| Jan-22 | 5.36 | 5.72 | 6.15 | 5.32 |
| Jan-23 | 5.69 | 5.54 | 5.70 | 5.40 |
| Jan-26 | 5.50 | 5.34 | 5.56 | 5.26 |
| Jan-27 | 5.30 | 5.93 | 5.97 | 5.30 |
| Jan-28 | 5.91 | 5.90 | 6.11 | 5.60 |
| Jan-29 | 5.88 | 5.74 | 6.14 | 5.65 |
| Jan-30 | 5.69 | 5.69 | 5.88 | 5.38 |
| Feb-2 | 5.57 | 6.09 | 6.12 | 5.57 |
| Feb-3 | 6.12 | 6.07 | 6.17 | 5.82 |
| Feb-4 | 6.19 | 5.67 | 6.35 | 5.49 |
| Feb-5 | 5.62 | 5.24 | 5.85 | 5.17 |
| Feb-6 | 5.30 | 5.67 | 5.78 | 5.30 |
CytomX Therapeutics, Inc. Earnings
CytomX Therapeutics, Inc. Earnings Report: Per Share CytomX Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
CytomX Therapeutics, Inc. Forecast Revenue Growth
CytomX Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for CytomX Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.03 per share.
* CytomX Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.